|Dec 3, 2003||
Theravance Announces Positive Phase 2 Results for Once-Daily Beta2-Agonists in Development for Asthma and COPD
|Nov 24, 2003|
|Sep 24, 2003||
Theravance Announces Promising Results From Multiple Research And Clinical Studies With the Investigational Antibiotic TD-6424
|Jan 6, 2003|
Data provided by Nasdaq.
Minimum 15 minutes delayed.
Sign up to receive important email alerts & updates from Innoviva.Sign up now
Innoviva Investor Relations & Media
For business development inquiries,
please contact firstname.lastname@example.org.